Astrazeneca Pharma I - Quarterly Results
10th Aug 2020

The sales for the June 2020 quarter moved down to Rs. 1935.77 millions as compared to Rs. 2045.61 millions during the year-ago period.The Net Profit of the company registered a slight decline of -13.39% to Rs. 186.34  millions from Rs. 215.16 millions.The company reported a degrowth in operating Profit to 312.20 millions from 385.52 millions.



(Rs. in Million)


  Quarter ended Year to Date Year ended
  202006 201906 % Var 202006 201906 % Var 202003 201903 % Var
Sales 1935.77 2045.61 -5.37 1935.77 2045.61 -5.37 8318.09 7282.94 14.21
Other Income 26.48 29.89 -11.41 26.48 29.89 -11.41 129.88 162.85 -20.25
PBIDT 312.20 385.52 -19.02 312.20 385.52 -19.02 1336.81 875.87 52.63
Interest 2.74 2.95 -7.12 2.74 2.95 -7.12 11.37 0.00 0.00
PBDT 309.46 382.57 -19.11 309.46 382.57 -19.11 1325.44 875.87 51.33
Depreciation 45.62 46.27 -1.40 45.62 46.27 -1.40 185.84 149.24 24.52
PBT 263.84 336.30 -21.55 263.84 336.30 -21.55 1139.60 726.63 56.83
TAX 77.50 121.14 -36.02 77.50 121.14 -36.02 417.50 182.23 129.11
Deferred Tax -8.46 -5.82 45.36 -8.46 -5.82 45.36 102.40 15.45 562.78
PAT 186.34 215.16 -13.39 186.34 215.16 -13.39 722.10 544.40 32.64
Equity 50.00 50.00 0.00 50.00 50.00 0.00 50.00 50.00 0.00
PBIDTM(%) 16.13 18.85 -14.42 16.13 18.85 -14.42 16.07 12.03 33.63